- Home
- BRTX vs MTR Comparison
BRTX vs MTR Comparison
Compare BRTX & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- MTR
- Stock Information
- Founded
- BRTX 1997
- MTR 1979
- Country
- BRTX United States
- MTR United States
- Employees
- BRTX N/A
- MTR N/A
- Industry
- BRTX Managed Health Care
- MTR Oil & Gas Production
- Sector
- BRTX Health Care
- MTR Energy
- Exchange
- BRTX Nasdaq
- MTR Nasdaq
- Market Cap
- BRTX 11.3M
- MTR 11.8M
- IPO Year
- BRTX N/A
- MTR N/A
- Fundamental
- Price
- BRTX $1.41
- MTR $6.33
- Analyst Decision
- BRTX Strong Buy
- MTR
- Analyst Count
- BRTX 1
- MTR 0
- Target Price
- BRTX $18.00
- MTR N/A
- AVG Volume (30 Days)
- BRTX 100.5K
- MTR 14.1K
- Earning Date
- BRTX 11-12-2024
- MTR 01-01-0001
- Dividend Yield
- BRTX N/A
- MTR 3.56%
- EPS Growth
- BRTX N/A
- MTR N/A
- EPS
- BRTX N/A
- MTR 0.35
- Revenue
- BRTX $377,000.00
- MTR $966,169.00
- Revenue This Year
- BRTX $482.76
- MTR N/A
- Revenue Next Year
- BRTX $212.24
- MTR N/A
- P/E Ratio
- BRTX N/A
- MTR $18.20
- Revenue Growth
- BRTX 189.55
- MTR N/A
- 52 Week Low
- BRTX $1.03
- MTR $5.60
- 52 Week High
- BRTX $3.67
- MTR $14.49
- Technical
- Relative Strength Index (RSI)
- BRTX 41.13
- MTR 43.26
- Support Level
- BRTX $1.40
- MTR $6.06
- Resistance Level
- BRTX $1.60
- MTR $6.79
- Average True Range (ATR)
- BRTX 0.10
- MTR 0.31
- MACD
- BRTX 0.00
- MTR -0.10
- Stochastic Oscillator
- BRTX 42.86
- MTR 20.77
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.